NEW YORK--(BUSINESS WIRE)--Kirby McInerney LLP is investigating potential claims against the Board of Directors of AngioDynamics, Inc. (“AngioDynamics” or the “Company”) (NASDAQ:ANGO) for possible breaches of fiduciary duty and other violations of state law. The investigation focuses on allegations that certain statements issued by the Company, between October 9, 2014 and April 9, 2015, regarding AngioDynamics’ business, operations, and prospects were false or misleading. On April 9, 2015 the C
| < Prev | Next > |
|---|
